8-KThe WireRoutine
Bylaw Amendment
Filed May 13, 2022 · 4y ago · Accession 0001683168-22-003584
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CNBX Pharmaceuticals Inc.
- Ticker
- CNBX
- CIK
- 1343009
- Form type
- 8-K
- Filing date
- May 13, 2022
- Report date
- May 10, 2022
- Document
- cnbx_8k.htm
- Size
- 426 KB